SINCROLAB SL
SINCROLAB SL is a Spanish private limited company (sociedad limitada) registered under CIF/NIF B86843737. It was incorporated on 17 October 2013 and its registry status is currently Active. Commercial registry sources record the company’s registered office in Malaga, Spain, under the Registro Mercantil de Malaga, and other commercial data sources indicate it has also maintained office locations in Madrid.
SINCROLAB SL develops artificial-intelligence-based digital therapeutics for neurocognitive disorders, with its principal product focused on the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged approximately 6 to 15 and cognitive decline in older adults. Its platform, marketed under the Sincrolab and Mental Twins brands, combines a gamified mobile application for patients with a professional web platform used by clinicians to monitor treatment. The company’s activity is classified under CNAE 6210 (computer programming activities). SINCROLAB SL has obtained CE Class IIa medical-device certification for its digital ADHD treatment and reports that its platform is used by more than 800 therapists across over 100 specialised centres in Spain.
Commercial data providers report SINCROLAB SL employed approximately 11 to 12 people between 2023 and 2025, with estimated annual revenue in the range of EUR 0.6 million to EUR 1.5 million for the 2025 financial year; these figures are third-party commercial estimates rather than figures confirmed directly by the company. SINCROLAB SL is not listed on any stock exchange. Between February 2022 and June 2026, the company completed several disclosed private funding rounds, including a EUR 1 million round led by pharmaceutical company Laboratorios Rubio (16 February 2022), a EUR 1.7 million round led by the Clave Innohealth fund, and further investment from Eoniq.fund reaching a cumulative EUR 335,000 by June 2026 at a reported pre-money valuation of EUR 8.5 million.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
Shareholders of SINCROLAB SL
Spain’s Registro Mercantil does not routinely publish a public shareholder register or capitalisation table for private limited companies such as SINCROLAB SL, so no complete list of shareholders or ownership percentages is available from official registry sources for this profile.
Publicly reported financing rounds identify several named investors that have taken stakes in the company, without disclosing the resulting percentage holdings. Pharmaceutical company Laboratorios Rubio led a EUR 1 million investment round on 16 February 2022, alongside undisclosed business angels and German family office JRV Holding. A further EUR 1.7 million round was led by the Clave Innohealth fund managed by Clave Capital, with participation from Growth Venture Partners and Eoniq.fund. Eoniq.fund subsequently increased its position to a cumulative EUR 335,000 by June 2026, at a reported pre-money valuation of EUR 8.5 million. Company founder Ignacio Vicente de Ramon Burgos is understood to retain an operational leadership role at SINCROLAB SL, but his current shareholding percentage is not disclosed.
Ultimate beneficial ownership
No authoritative source reviewed for this profile identifies a verified ultimate beneficial owner of SINCROLAB SL, and the available ownership chain is incomplete, so no UBO or effective ownership percentage is stated here.
Data availability
Shareholder and UBO information for SINCROLAB SL is classified as Not public for the official Spanish commercial registry, and Partial for market data: press-reported investors are identified by name, but no source discloses their ownership percentages or a complete capitalisation table.
Sources
- Infonif, company registry summary (NIF B86843737), https://infonif.economia3.com/ficha-empresa/sincrolab-sl, retrieved 2026-09-23
- Empresite (El Economista), company profile, https://empresite.eleconomista.es/SINCROLAB.html, retrieved 2026-09-23
- PlantaDoce, "Sincrolab cierra una ronda de un millon de euros liderada por Laboratorios Rubio", 16 February 2022, https://www.plantadoce.com/empresa/sincrolab-cierra-una-ronda-de-un-millon-de-euros-liderada-por-laboratorios-rubio, retrieved 2026-09-23
- Biotech Spain, "Laboratorios Rubio y Sincrolab se unen en el tratamiento del TDAH", https://biotech-spain.com/es/articles/laboratorios-rubi-y-sincrolab-se-unen-en-el-tratamiento-del-tdah/, retrieved 2026-09-23
- Webcapitalriesgo, "Eoniq.fund redobla su apuesta por Sincrolab", 22 June 2026, https://www.webcapitalriesgo.com/eoniq-fund-redobla-su-apuesta-por-sincrolab-ia-terapia-cognitiva-con-una-inversion-de-e100-000/, retrieved 2026-09-23
- elReferente.es, "Sincrolab obtiene 1,7M en una ronda de inversion", https://elreferente.es/inversiones/sincrolab-obtiene-17m-ronda-inversion-liderada-fondo-clave-innohealth/, retrieved 2026-09-23
Officers
7
Directors and officers of SINCROLAB SL
Registry-derived aggregator data identifies at least one current officer of SINCROLAB SL: Ignacio Vicente de Ramon Burgos, who has served as Presidente (President), Consejero (Board Member) and Apoderado Solidario (joint power of attorney holder) since 17 August 2017. He previously served as the company’s Administrador Unico (Sole Administrator) from 2 January 2015 until 17 August 2017, when the company’s governance structure changed from a sole administrator to a board (consejo de administracion) format. Ignacio de Ramon is also identified in press coverage as SINCROLAB SL’s Chief Executive Officer and co-founder.
One commercial data provider references further board changes during 2026, including a possible corporate board appointment, but these later changes could not be independently confirmed from a primary BORME registry filing within the sources reviewed for this profile, so they are not stated as verified here. No resignations, removals or other named current officers could be independently verified from the sources reviewed.
Data availability
Officer information for SINCROLAB SL is classified as Partial: aggregator data confirms one current officer position with an appointment date, but a complete, up-to-date list of all current directors, secretaries or legal representatives was not independently verifiable from primary BORME filings within the sources reviewed. Nationality and country of residence are not disclosed in any source reviewed for this profile.
Sources
- Empresia.es, position history for De Ramon Burgos Ignacio Vicente, https://www.empresia.es/persona/de-ramon-burgos-ignacio-vicente/, retrieved 2026-09-23
- Biotech Spain, CEO identification, https://biotech-spain.com/es/articles/laboratorios-rubi-y-sincrolab-se-unen-en-el-tratamiento-del-tdah/, retrieved 2026-09-23
- Infonif, https://infonif.economia3.com/ficha-empresa/sincrolab-sl, retrieved 2026-09-23
Registry feed — rows exactly as filed with Colegio de Registradores / Registro Mercantil Central, including entries the profile above does not cover.
Group Structure
Group structure of SINCROLAB SL
No official filing or registry source reviewed for this profile confirms that SINCROLAB SL has an immediate or ultimate parent company, or that it holds a controlling stake in any subsidiary. The company’s funding history shows that pharmaceutical company Laboratorios Rubio led a EUR 1 million investment round in February 2022 and that other institutional investors, including the Clave Innohealth fund, Growth Venture Partners and Eoniq.fund, subsequently took stakes through further funding rounds. None of these relationships is confirmed by an official filing as amounting to majority ownership or corporate control, so they are described here as disclosed investors rather than as a parent company.
One commercial data aggregator (Infonif) labels Laboratorios Rubio as a "parent company" of SINCROLAB SL, but this label is not corroborated by an official registry filing or company announcement describing a controlling shareholding, so it is treated as a possible rather than a verified relationship. No direct or indirect subsidiaries of SINCROLAB SL were identified. On the evidence available, SINCROLAB SL appears to operate as an independent company with external minority investors rather than as part of a verified corporate group.
Data availability
Group-structure information for SINCROLAB SL is classified as Not found for a verified parent or subsidiary relationship: commercial-data aggregators reference a possible parent-company link and multiple investors, but none is corroborated by an official Spanish registry filing confirming a controlling ownership stake.
Sources
- Infonif, https://infonif.economia3.com/ficha-empresa/sincrolab-sl, retrieved 2026-09-23
- PlantaDoce, https://www.plantadoce.com/empresa/sincrolab-cierra-una-ronda-de-un-millon-de-euros-liderada-por-laboratorios-rubio, retrieved 2026-09-23
- Webcapitalriesgo, https://www.webcapitalriesgo.com/eoniq-fund-redobla-su-apuesta-por-sincrolab-ia-terapia-cognitiva-con-una-inversion-de-e100-000/, retrieved 2026-09-23
SINCROLAB SL
Spain
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What does SINCROLAB SL do?
Develops AI-based digital therapeutics for neurocognitive disorders, including a CE Class IIa certified ADHD platform for children and cognitive-training tools for older adults.
Who owns SINCROLAB SL?
Disclosed investors include Laboratorios Rubio, the Clave Innohealth fund, Growth Venture Partners and Eoniq.fund; ownership percentages not disclosed.
Who is SINCROLAB SL's UBO (Ultimate Beneficial Owner)?
No Ultimate Beneficial Owner (UBO) data is recorded for SINCROLAB SL; access to beneficial-ownership data in this jurisdiction is governed by its own register rules.
What is SINCROLAB SL's company registration number?
SINCROLAB SL's registration number is B86843737, filed with Colegio de Registradores / Registro Mercantil Central in Spain. Its current status on the register is active.
Is SINCROLAB SL still an active company?
SINCROLAB SL's status on Colegio de Registradores / Registro Mercantil Central is listed as active.
What is SINCROLAB SL's registered address?
The registered address on file for SINCROLAB SL is MADRID, Spain.
What legal structure is SINCROLAB SL registered as?
SINCROLAB SL is registered as a Private limited company (Ltd.) in Spain.
What is SINCROLAB SL's revenue?
Estimated EUR 0.6-1.5 million for 2025 (third-party commercial estimate, not company-confirmed).
Is SINCROLAB SL listed on a stock exchange?
Not listed on any stock exchange.
Who are the officers/directors of SINCROLAB SL?
Ignacio Vicente de Ramon Burgos has served as President/Board Member since 2017 and is also identified as CEO and co-founder.
Does SINCROLAB SL have a parent company or subsidiaries?
No verified parent company or subsidiaries; operates as an independent company with disclosed minority investors.
Can Zavia monitor changes to SINCROLAB SL's ownership over time?
This profile reflects a point-in-time snapshot from Colegio de Registradores / Registro Mercantil Central. Zavia's monitoring API can track changes to SINCROLAB SL's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access SINCROLAB SL's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Spain, so records like SINCROLAB SL's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Colegio de Registradores / Registro Mercantil Central and was last synced on 25 September 2026.